Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Student gives hope to childhood cancer patients

2015-10-16

Siphokuhle Jama believes that the underprivileged are also destined to reign.

The inaugural ‘Dance and Musical Childhood Cancer Fundraising Day’, held on Saturday 26 September 2015 at the Free State Childhood Cancer (CHOC) Foundation, was “a huge success,” according to Siphokuhle Jama, the organiser.

Siphokuhle is a second-year BSc Agricultural Economics student at the University of the Free State (UFS), who has devoted his life to bettering the lives of the less fortunate. The 21-year-old self-proclaimed motivational speaker, entrepreneur, and budding author was inspired by his humble beginnings to found the Destined to Reign Foundation, which champions various community initiatives in both his home town of Mtata and Bloemfontein.

To support the fight against childhood cancer, the young philanthropist took it upon himself to invite music and dance fanatics either to perform or to enjoy spectatorship for a good cause. The impressive support received from the UFS, Universitas Academic Hospital, and Central University of Technology (CUT), various artists, and the community has contributed towards ensuring that the inaugural fundraiser was a prelude to annual events to come.

Singers, dancers, and poets entertained the audience with vigour, making the day one of the most special for the young children, who spend their days and nights at the CHOC House, with little to do but undergo radiation and chemotherapy and await a discharge date. .

All proceeds went towards basic needs, such as food, toiletries, and clothing for the children residing at the House, which is located in the same suburb as our university. In addition to accommodating dozens of cancer patients and their mothers, the House also assists with the treatment and rehabilitation of children suffering from life-threatening blood disorders. Thus, the fundraiser served to promote awareness of these health conditions.

Siphokuhle’s passion for giving hope to the underprivileged was unveiled by a school community engagement project 14 years ago. He has never looked back.“It has always been in my heart to serve my community,” he said.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept